In this week’s DeviceTalks Weekly, new Virtual Incision CEO Jim Alecxih walks us through his career, including a critical role at Intuitive Surgical, and explains why the Mira surgical robotic system convinced him to return to the industry. Olympus Ventures’ Abby Hunter-Syed keeps an eye on the broader tumult impacting MedTech. Chris Newmarker delivers the Newmarker’s Newsmakers – Insulet, Recor, Abbott, Ambu, GE Healthcare, Intuitive, Terumo and OrganOx.
This episode is sponsored by DeviceTalks West. Check out the agenda and register at West.DeviceTalks.com.
Thank you for listening to the DeviceTalks Podcast Network.
***
Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters
(00:02:50) - Show Open/Newmarker’s Newsmakers(00:05:25) - Insulet promotes Eric Benjamin to COO role(00:07:17) - Recor Medical's Paradise renal denervation tech wins Japanese approval(00:09:51) - Two Abbott MedTech executives leaving for new roles(00:13:03) - Intuitive announces layoffs?(00:16:35) - Terumo to acquire organ preservation device maker OrganOx for $1.5B(00:20:15) - FOMO – Abby Hunter-Syed, Sr. Director, Olympus Ventures(00:29:45) - Keynote – Jim Alecxih, CEO, Virtual Incision(00:37:07) - Early reactions to a surgical robot(00:42:40) - The Xbox /The Four Ps of Value Proposition(00:45:16) - Technology = Quality care(01:08:52) - Mira is different(01:10:12) - We're not a Ferrari. We’re an F150(01:14:57) - Message to patients

Ver todos los episodios